In response to the proposal presented by Fresenius Medical Care, the Subject Expert Committee (SEC) functional under the ...

The proposed nomogram demonstrated strong predictive accuracy and clinical usefulness, offering a valuable tool for early ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika ...

Opening of Japan’s first clinical trial site for ACTION3 triggers the first development milestone payment of ¥400 million ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation ...

Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...

Phoenix resident Sejal Patel didn’t know what to think when she started having anemia symptoms while she was going to medical school. In 2006, Patel, then 25, had been a Type 1 diabetes ...

NICE reversed its earlier decision on sparsentan for treating primary immunoglobulin A nephropathy after additional evidence ...

Jenny Ahlstrom, 57, was diagnosed with multiple myeloma, a form of blood cancer, in 2010. Following her diagnosis, she was ...